针对胰腺癌的疫苗基疗法取得了进展
Matthew T McMillan1,2, Kevin C Soares3,4
1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Journal of gastrointestinal cancer
|February 12, 2025
概括
胰腺癌 (PDAC) 是一种致命的疾病,存活率很低. 针对新抗原和KRAS突变的新型癌症疫苗在增强抗瘤免疫力和改善PDAC患者的结果方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症 疫苗 癌症 疫苗
背景情况:
- 胰腺管道腺癌 (PDAC) 是一种高度致命的癌症,其5年生存率令人丧.
- 由于免疫抑制性瘤微环境和低免疫性,PDAC的特征是早期转移,肝脏热带性和对免疫治疗的耐药性.
- 导致免疫抵抗的因素包括低突变负担,缺陷的抗原呈现,以及上调的免疫检查点,将PDAC归类为"免疫感冒"瘤.
研究的目的:
- 探索新的治疗策略,以克服PDAC对传统治疗的耐药性,并重振抗瘤免疫力.
- 评估个性化mRNA新抗原疫苗和突变KRAS向疫苗在治疗PDAC的潜力.
- 评估将疫苗方法与化疗,手术和放射治疗等标准疗法结合在一起的影响.
主要方法:
- 研究了PDAC癌症疫苗开发的最新进展.
- 对辅助型个性化mRNA新抗原疫苗和突变KRAS向疫苗的临床试验数据进行了审查.
- 研究了瘤微环境和免疫逃避机制在PDAC治疗耐药性的作用.
主要成果:
- 个性化mRNA新抗原疫苗和突变KRAS向疫苗已经在PDAC中显示了持续的T细胞反应.
- 这些疫苗诱导的T细胞反应与手术切除的PDAC中改善的无复发生存率有关.
- 涉及疫苗和标准疗法的组合策略显示出改善治疗结果的潜力.
结论:
- PDAC疫苗代表了一种有前途的治疗策略,可以克服治疗耐药性并改善长期存活率.
- 目前正在进行的临床试验正在探索PDAC疫苗在各种治疗环境中的有效性.
- 进一步研究组合疗法和最佳测序对于最大限度地提高PDAC疫苗的益处至关重要.
相关概念视频
Cancer Vaccines
329
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Chronic Pancreatitis II: Collaborative Care
60
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
60
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


